Compare IDEXX Laboratories, Inc. (IDXX) vs United Airlines Holdings Inc (UAL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs United Airlines Holdings Inc — how do they compare? IDEXX Laboratories, Inc. trades at $558.29 (market cap $44.48B), while United Airlines Holdings Inc trades at $117.57 (market cap $38.15B). The key difference: IDEXX Laboratories, Inc. is the larger of the two by market cap, and United Airlines Holdings Inc is trading nearer its 52-week high, IDEXX Laboratories, Inc. nearer its low. Which is the better fit depends on your goals.
| IDXX | UAL | |
|---|---|---|
Market Cap | $44.48B | $38.15B |
Sector | Health | Industrials |
52-Week High | $766.68 | $136.11 |
52-Week Low | $520.87 | $84.57 |
Enterprise Value | $45.38B | $55.18B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDXX trades at $563.79, down 0.64% today but maintains strong fundamental momentum with consistent earnings beats and robust profitability. The stock shows bullish technical signals with support at $563 and resistance at $572, while valuation metrics remain elevated. Recent Q1 2026 results exceeded expectations with EPS of $3.47 versus $3.41 estimates, supporting the company's leadership in veterinary diagnostics.
Outlook remains positive given strong analyst support (59% buy ratings) and innovation pipeline, though premium valuations and competitive pressures present risks. Revenue growth trajectory and expanding margins provide fundamental support for continued upside potential in the pet healthcare sector.
United Airlines (UAL) trades at $116.77, up 1.18% with a bullish technical signal despite mixed moving averages. The company shows strong fundamentals with a P/E of 10.81 and consistent earnings beats, including Q2 2026 EPS of $1.99 versus $1.88 expected. Revenue growth is robust, rising to $59.07B in 2025, though fuel costs pose headwinds. Analyst consensus is strongly bullish with a $163.75 price target and no sell ratings among 47 analysts.
Outlook remains positive due to resilient travel demand and premium revenue growth, but investors face risks from volatile fuel prices and operational disruptions. The stock offers value with low valuation multiples and upward earnings revisions, yet macroeconomic sensitivity requires caution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About United Airlines Holdings Inc
United Airlines is a major U.S. network carrier. United's hubs include San Francisco, Chicago, Houston, Denver, Los Angeles, New York/Newark, and Washington, D.C. United operates a hub-and-spoke system that is more focused on international travel than legacy peers.
Read more on UAL →
